IBDEI2KZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43808,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,43809,0)
 ;;=D06.1^^170^2107^21
 ;;^UTILITY(U,$J,358.3,43809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43809,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,43809,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,43809,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,43810,0)
 ;;=N60.11^^170^2107^33
 ;;^UTILITY(U,$J,358.3,43810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43810,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Right Breast
 ;;^UTILITY(U,$J,358.3,43810,1,4,0)
 ;;=4^N60.11
 ;;^UTILITY(U,$J,358.3,43810,2)
 ;;=^5015773
 ;;^UTILITY(U,$J,358.3,43811,0)
 ;;=N60.12^^170^2107^32
 ;;^UTILITY(U,$J,358.3,43811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43811,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Left Breast
 ;;^UTILITY(U,$J,358.3,43811,1,4,0)
 ;;=4^N60.12
 ;;^UTILITY(U,$J,358.3,43811,2)
 ;;=^5015774
 ;;^UTILITY(U,$J,358.3,43812,0)
 ;;=N63.^^170^2107^61
 ;;^UTILITY(U,$J,358.3,43812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43812,1,3,0)
 ;;=3^Lump in Breast,Unspec
 ;;^UTILITY(U,$J,358.3,43812,1,4,0)
 ;;=4^N63.
 ;;^UTILITY(U,$J,358.3,43812,2)
 ;;=^5015791
 ;;^UTILITY(U,$J,358.3,43813,0)
 ;;=N73.9^^170^2107^48
 ;;^UTILITY(U,$J,358.3,43813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43813,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43813,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,43813,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,43814,0)
 ;;=N72.^^170^2107^55
 ;;^UTILITY(U,$J,358.3,43814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43814,1,3,0)
 ;;=3^Inflammatory Disease of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,43814,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,43814,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,43815,0)
 ;;=N76.0^^170^2107^93
 ;;^UTILITY(U,$J,358.3,43815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43815,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,43815,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,43815,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,43816,0)
 ;;=N76.1^^170^2107^95
 ;;^UTILITY(U,$J,358.3,43816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43816,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,43816,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,43816,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,43817,0)
 ;;=N81.3^^170^2107^88
 ;;^UTILITY(U,$J,358.3,43817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43817,1,3,0)
 ;;=3^Uterovaginal Prolapse,Complete
 ;;^UTILITY(U,$J,358.3,43817,1,4,0)
 ;;=4^N81.3
 ;;^UTILITY(U,$J,358.3,43817,2)
 ;;=^5015840
 ;;^UTILITY(U,$J,358.3,43818,0)
 ;;=N81.2^^170^2107^89
 ;;^UTILITY(U,$J,358.3,43818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43818,1,3,0)
 ;;=3^Uterovaginal Prolapse,Incomplete
 ;;^UTILITY(U,$J,358.3,43818,1,4,0)
 ;;=4^N81.2
 ;;^UTILITY(U,$J,358.3,43818,2)
 ;;=^5015839
 ;;^UTILITY(U,$J,358.3,43819,0)
 ;;=N81.4^^170^2107^90
 ;;^UTILITY(U,$J,358.3,43819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43819,1,3,0)
 ;;=3^Uterovaginal Prolapse,Unspec
 ;;^UTILITY(U,$J,358.3,43819,1,4,0)
 ;;=4^N81.4
 ;;^UTILITY(U,$J,358.3,43819,2)
 ;;=^5015841
 ;;^UTILITY(U,$J,358.3,43820,0)
 ;;=N87.9^^170^2107^38
 ;;^UTILITY(U,$J,358.3,43820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43820,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,43820,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,43820,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,43821,0)
 ;;=N87.0^^170^2107^22
 ;;^UTILITY(U,$J,358.3,43821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43821,1,3,0)
 ;;=3^Cervical Dysplasia,Mild
 ;;^UTILITY(U,$J,358.3,43821,1,4,0)
 ;;=4^N87.0
 ;;^UTILITY(U,$J,358.3,43821,2)
 ;;=^5015875
